BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34988151)

  • 1. Syngeneic bone marrow transplantation in combination with PI3K inhibitor reversed hyperglycemia in later-stage streptozotocin-induced diabetes.
    Zhang S; Dai Q; Zhang B; Liu S; Wang Y; Zhang Y; Chen D; Zong N; Wang H; Ding J; Gao Q; Wen Y
    Ann Transl Med; 2021 Nov; 9(22):1642. PubMed ID: 34988151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time point is important for effects of syngeneic bone marrow transplantation for type 1 diabetes in mice.
    Wen Y; Ouyang J; Li W; Chen J; Liu Y; Meng L; Zhang H; Zhou X
    Transplant Proc; 2009 Jun; 41(5):1801-7. PubMed ID: 19545732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune changes in type 1 diabetes animal model after syngeneic bone marrow transplantation].
    Lü CL; Ouyang J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):726-30. PubMed ID: 20561438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The variance of peripheral blood lymphocyte subsets of streptozotocin-induced diabetic mice after bone marrow transplantation.
    Wang J; Lv C; Xie T; Ouyang J
    Int J Clin Exp Med; 2015; 8(3):4115-21. PubMed ID: 26064318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinatorial Treatment of Bone Marrow Transplantation and Regulatory T Cells Improves Glycemia in Streptozotocin-diabetic Mice.
    Min H; Ding J; Wen Y; Ma X; Gao Q
    Exp Clin Endocrinol Diabetes; 2015 Nov; 123(10):638-44. PubMed ID: 26625334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of new-onset type 1 diabetes in mice by syngeneic bone marrow transplantation.
    Wen Y; Ouyang J; Yang R; Chen J; Liu Y; Zhou X; Burt RK
    Biochem Biophys Res Commun; 2008 Sep; 374(2):282-7. PubMed ID: 18625200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive effects of syngeneic bone marrow transplantation on diabetic nephropathy in mice.
    Ouyang J; Hu G; Wen Y; Zhang X
    Transpl Immunol; 2010 Feb; 22(3-4):184-90. PubMed ID: 20045460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of an autoimmune encephalomyelitis mouse model with nonmyeloablative conditioning and syngeneic bone marrow transplantation.
    Meng L; Ouyang J; Zhang H; Wen Y; Chen J; Zhou J
    Restor Neurol Neurosci; 2011; 29(3):177-85. PubMed ID: 21586824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of phosphoinositide‑3 kinases γ/δ ameliorates pulmonary granuloma by rescuing Treg function in a sarcoidosis model.
    Zhang X; Dai Q; Shan J; Zhang S; Zhang B; Liu S; Zhang Y; Wang Y; Li X; Jin X; Liang D; Ding J; Wang Y; Wen Y
    Exp Ther Med; 2023 May; 25(5):225. PubMed ID: 37123205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 33 ameliorates disturbance of regulatory T cells in pulmonary sarcoidosis.
    Zhang B; Zhao F; Mao H; Ma W; Zhang Y; Zhang X; Ding J; Gao Q; Wen Y
    Int Immunopharmacol; 2018 Nov; 64():208-216. PubMed ID: 30195819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic Acid Suppresses Autoimmune Recurrence and Allograft Rejection in Islet Transplantation through Induction of the Differentiation of Regulatory T Cells and Can Be Used in Cell Therapy for Type 1 Diabetes.
    Lin JR; Huang SH; Wu CH; Chen YW; Hong ZJ; Cheng CP; Sytwu HK; Lin GJ
    Pharmaceuticals (Basel); 2021 May; 14(5):. PubMed ID: 34067829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous stem cell transplantation aids autoimmune patients by functional renewal and TCR diversification of regulatory T cells.
    Delemarre EM; van den Broek T; Mijnheer G; Meerding J; Wehrens EJ; Olek S; Boes M; van Herwijnen MJ; Broere F; van Royen A; Wulffraat NM; Prakken BJ; Spierings E; van Wijk F
    Blood; 2016 Jan; 127(1):91-101. PubMed ID: 26480932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of peripheral CD4+CD25+Foxp3+ T regulatory cells in mice with STZ-induced diabetes.
    Zhen Y; Sun L; Liu H; Duan K; Zeng C; Zhang L; Jin D; Peng J; Ding W; Zhao Y
    Cell Mol Immunol; 2012 Jan; 9(1):75-85. PubMed ID: 21983870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of tolerance and prolongation of islet allograft survival by syngeneic hematopoietic stem cell transplantation in mice.
    Yang SF; Xue WJ; Lu WH; Xie LY; Yin AP; Zheng J; Sun JP; Li Y
    Transpl Immunol; 2015 Oct; 33(2):130-9. PubMed ID: 26311302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of calcineurin abrogates while inhibition of mTOR promotes regulatory T cell expansion and graft-versus-host disease protection by IL-2 in allogeneic bone marrow transplantation.
    Satake A; Schmidt AM; Nomura S; Kambayashi T
    PLoS One; 2014; 9(3):e92888. PubMed ID: 24658577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.
    Yaochite JN; de Lima KW; Caliari-Oliveira C; Palma PV; Couri CE; Simões BP; Covas DT; Voltarelli JC; Oliveira MC; Donadi EA; Malmegrim KC
    Stem Cell Res Ther; 2016 Jan; 7():14. PubMed ID: 26781648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of transplantation tolerance induction by autologous regulatory T cells in the pig-to-non-human primate islet xenotransplantation model.
    Shin JS; Min BH; Kim JM; Kim JS; Yoon IH; Kim HJ; Kim YH; Jang JY; Kang HJ; Lim DG; Ha J; Kim SJ; Park CG
    Xenotransplantation; 2016 Jul; 23(4):300-9. PubMed ID: 27387829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress toward production of immunologic tolerance with no or minimal toxic immunosuppression for prevention of immunodeficiency and autoimmune diseases.
    Good RA
    World J Surg; 2000 Jul; 24(7):797-810. PubMed ID: 10833246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recipient-Derived Allo-iTregs Induced by Donor DCs Effectively Inhibit the Proliferation of Donor T Cells and Reduce GVHD.
    Yang ZG; Wen RT; Feng JS; Cao PJ; Zhou HT; Liu WX
    Anat Rec (Hoboken); 2019 May; 302(5):825-836. PubMed ID: 30312018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of redox status of peripheral blood on immune signature of circulating regulatory and cytotoxic T cells in streptozotocin induced rodent model of type I diabetes.
    Anupam K; Kaushal J; Prabhakar N; Bhatnagar A
    Immunobiology; 2018 Oct; 223(10):586-597. PubMed ID: 30017263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.